A Phase II, Multi-center, Randomised, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Clonidine Lauriad 50 μg and 100 μg Mucoadhesive Buccal Tablet (MBT) Applied Once Daily to Those of Placebo in the Prevention and Treatment of Chemoradiation Therapy Induced Oral Mucositis in Patients With Head and Neck Cancer

Trial Profile

A Phase II, Multi-center, Randomised, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Clonidine Lauriad 50 μg and 100 μg Mucoadhesive Buccal Tablet (MBT) Applied Once Daily to Those of Placebo in the Prevention and Treatment of Chemoradiation Therapy Induced Oral Mucositis in Patients With Head and Neck Cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Nov 2017

At a glance

  • Drugs Clonidine (Primary)
  • Indications Stomatitis
  • Focus Therapeutic Use
  • Sponsors BioAlliance Pharma; Onxeo SA
  • Most Recent Events

    • 22 Oct 2015 Compliance and patient acceptability results presented at the 57th American Society for Radiation Oncology (ASTRO) Annual Meeting 2015, according to an Onxeo SA media release.
    • 22 Oct 2015 Compliance and patient acceptability results published in the Media Release
    • 19 Oct 2015 Results will be presented at the 57th American Society for Radiation Oncology (ASTRO) Annual Meeting, according to an Onexo SA media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top